Introduction: Cord blood (CB) is becoming a valuable source for stem cells utilized in a variety of cell therapy applications, as well as for newborn diagnostics. Some parameters of the CB cellular components can be provided by automated analyzers, while others, such as immature or aberrant cells, require blood film morphological assessment. The objectives of the study were to establish normal CB morphology and to determine the prevalence of morphologically aberrant leukocytes in CB. Methods: We performed a comprehensive morphological analysis of 100 CB samples taken from healthy term and appropriate-for-gestational-age neonates born to healthy mothers, preterm neonates, neonates of diabetic mothers, and small-for-gestational-age neonates. Blood counts were assessed, and manual morphological analyses were performed by laboratory specialists. Results: The manual differential count of normal CB samples established the following values: 47.8 ± 10.7% neutrophils, 31.2 ± 9.8% lymphocytes, 10.0 ± 4.0% monocytes, and 3.0 ± 2.5% eosinophils, with no significant sex-related differences. Blasts were observed in 44/100 samples with an average of 0.5 ± 0.7% per sample, and only a minor left shift was observed. There were significant populations of large granular lymphocytes (19.1 ± 10.6% of the total lymphocytes) and morphologically aberrant lymphocytes (12.4 ± 5.4% of the total lymphocytes) in the samples, irrespective of neonatal status. The differentials of preterm CB samples differ significantly from normal term CB samples, including the reverse of neutrophils/lymphocytes ratio, and the lack of basophils. Conclusions: Normal values and unique morphological features in the CB of neonates are described. The abundant morphologically aberrant lymphocytes in CB may represent an immature state of the immune system at birth.

For several decades, cord blood (CB) has been a valuable source of hematopoietic stem cells both for research and for various clinical applications [1, 2]. New potentials are continuously emerging in the field of CB-derived therapy, including gene editing [1] and tissue regeneration [3]. However, CB can also be utilized for the diagnosis of various diseases and conditions in the newborn. Several attempts have been made to sample CB for diagnostic purposes. For example, it has been suggested that CB could be tested for bilirubin, direct antiglobulin, and ABO typing in order to detect significant hyperbilirubinemia in neonates [4]. Some laboratory tests performed on CB, including the measurement of hepcidin [5], interleukin (IL)-6, and procalcitonin [6], can be used as biomarkers for early-onset neonatal sepsis. Several studies have indicated that CB-derived complete blood count (CBC) can often spare the need to draw blood samples from newborns, which is especially problematic for premature infants [7-9]. Hematological reference ranges for CB have been established [10], but CBC-derived differential counts may not be dependable [11]. While CB-derived CBCs may provide information on critical clinical parameters, such as hemoglobin levels and platelets counts, they do not provide information on other parameters, such as the levels of reactive lymphocytes, immature cells, and blasts. Those latter parameters can be important for diagnosing clinical entities, such as sepsis, the neonatal syndrome transient abnormal myelopoiesis, and the subsequent Down syndrome-associated acute myeloid leukemia [12], but they can only be obtained from morphological assessments. Previous studies indicated that leukocyte populations in the CB may differ from normal peripheral blood (PB), not only with respect to the presence of immature cells, but other cell types as well. For example, natural killer (NK) cells constitute up to 10% of lymphocytes in PB and up to 30% in CB [13]. The aim of this study was to determine normal CB morphology and to identify morphological abnormalities in CB.

Sample Collection

One hundred samples were collected over a period of a year. The 100 analyzed CB samples were from 54 male and 46 female neonates. The umbilical CB samples were collected ex utero after clamping of the cord prior to expulsion of the placenta. CB collections were carried out by obstetricians or midwives in the delivery room. The samples were collected into a spray-dried K3EDTA vacuum tube (Greiner, Kremsmunster, Austria), and were analyzed in DxH800 Beckman Coulter CBC analyzers (Brea, CA, USA).

Clinical Parameters

Clinical parameters were retrospectively reviewed from the medical records and were evaluated for their potential effect on CB values. Those parameters included gestational age (GA), sex, birth weight, APGAR score, and clinical information on the maternal health status, such as chronic diseases, abnormalities and/or complications of labor, and prior and current drug treatment. GA was determined by the first-trimester ultrasound, by obstetrical dating of the pregnancy, and/or by examination of the infant after birth.

Blood Film Preparation and Morphological Analysis

The average period from sample collection to CBC count/slide preparation in the laboratory is 26 ± 41 min. Blood films were automatically prepared on glass slides (SP-Slides, Sysmex, Lincolnshire, IL, USA) by a Beckman Coulter Slide Maker Stainer (Brea, CA, USA) and stained according to the following protocol: methanol (absolute, Bio-Lab Ltd., Jerusalem, Israel) 4 min 1 s; May Grunwald stain (TruColor, Beckman Coulter, Brea, CA, USA) 6 min 22 s; water (double distilled, Terion, Cary, NC, USA) 3 min; Giemsa stain (TruColor, Beckman Coulter, Brea, CA, USA) 9 min; water (double distilled, Terion, Cary, NC) 1 min; air dry: 6 min. Morphological analysis was performed by the DM1200 CellaVision image analyzer, followed by review and approval by a certified laboratory specialist. A total of 150 cells were collected for each analysis. Detailed analysis of lymphocytes morphology by a certified laboratory specialist was performed on 100 lymphocytes (100% total). Aberrations in lymphoid cells in the PB were defined by the ICSH as “… increased cell size, immaturity of the nucleus including a visible nucleolus and lack of chromatin condensation, irregular nuclear outline or lobulation, cytoplasmic basophilia and vacuolation, and irregular cell outline. The cytoplasm may be abundant with staining varying from pale blue to markedly basophilic especially at points of contact with adjacent cells” [14]. Reactive lymphocytes were classified as cells that characterize viral infections, and include “variant, reactive, abnormal, activated and atypical lymphocytes, Downey cells Type1–3, Turk cells, immunoblasts and even combinations of cells,” according to the definition by the ICSH [14].

Statistical Analysis

Statistical significances of the experiments presented in Figures 1-4, as well as in online supplementary Figure 1 (for all online suppl. material, see www.karger.com/doi/10.1159/000520638) were determined by Student’s t test, and p values <0.05 were considered statistically significant.

Fig. 1.

a Hematological assessment of CB samples. CBC was performed on 100 CB samples. Distribution of hemoglobin, RBC, MCH, platelets, and WBC are presented according to sex variable (F – female, N = 46; M – male, N = 54). High, low, and average values (detailed in the text) for each parameter are shown. The overall average (dashed line) is shown with the averages and distribution among female (F) and male (M) samples. *Significant (p < 0.007) difference between female and male samples. b Morphological assessment of CB samples. Manual differential count was performed on 100 CB samples. Differential counts of the major types of leukocytes according to sex variable (F – female, N = 46; M – male, N = 54) are presented. The overall average (dashed line) is shown with the averages and distribution of samples among female (F) and male (M) samples. CB, cord blood; CBC, complete blood count; RBCs, red blood cells; MCH, mean corpuscular hemoglobin; WBC, white blood cells.

Fig. 1.

a Hematological assessment of CB samples. CBC was performed on 100 CB samples. Distribution of hemoglobin, RBC, MCH, platelets, and WBC are presented according to sex variable (F – female, N = 46; M – male, N = 54). High, low, and average values (detailed in the text) for each parameter are shown. The overall average (dashed line) is shown with the averages and distribution among female (F) and male (M) samples. *Significant (p < 0.007) difference between female and male samples. b Morphological assessment of CB samples. Manual differential count was performed on 100 CB samples. Differential counts of the major types of leukocytes according to sex variable (F – female, N = 46; M – male, N = 54) are presented. The overall average (dashed line) is shown with the averages and distribution of samples among female (F) and male (M) samples. CB, cord blood; CBC, complete blood count; RBCs, red blood cells; MCH, mean corpuscular hemoglobin; WBC, white blood cells.

Close modal
Fig. 2.

Morphological assessment of lymphocytes subtypes. Representative examples of: LGLs (a), Reactive (viral) lymphocytes (b), Aberrant lymphocytes (c). Arrows: cleft nucleus, black arrowheads: cytoplasmic blebs, and dashed arrows: reticulated nucleus and white arrowhead: nucleoli (blast-like cell). d Differential count of lymphocytes subtypes. High, low, and average values (detailed in the text) for each parameter are shown.LGL, large granular lymphocytes; SD, standard deviation.

Fig. 2.

Morphological assessment of lymphocytes subtypes. Representative examples of: LGLs (a), Reactive (viral) lymphocytes (b), Aberrant lymphocytes (c). Arrows: cleft nucleus, black arrowheads: cytoplasmic blebs, and dashed arrows: reticulated nucleus and white arrowhead: nucleoli (blast-like cell). d Differential count of lymphocytes subtypes. High, low, and average values (detailed in the text) for each parameter are shown.LGL, large granular lymphocytes; SD, standard deviation.

Close modal
Fig. 3.

CB samples classification according to neonatal status. Eighty-eight CB samples were analyzed in groups (A–F) according to different neonatal statuses as depicted in the table (right). Left: the average ± SD of the weight at birth, GA and APGAR 5 of the samples in each group. *Significant (p < 0.05) difference compared to the normal samples (group A). Dashed line: Group A level. GA, gestational age; LGLs, large granular lymphocytes, SD, standard deviation.

Fig. 3.

CB samples classification according to neonatal status. Eighty-eight CB samples were analyzed in groups (A–F) according to different neonatal statuses as depicted in the table (right). Left: the average ± SD of the weight at birth, GA and APGAR 5 of the samples in each group. *Significant (p < 0.05) difference compared to the normal samples (group A). Dashed line: Group A level. GA, gestational age; LGLs, large granular lymphocytes, SD, standard deviation.

Close modal
Fig. 4.

Differential count of the major types of leukocytes according to neonatal status. The averages ± SD of % of neutrophils, lymphocytes, monocytes, eosinophils, and basophils according to different neonatal statuses (A–F) are shown. * Significant (p < 0.05) difference compared to the normal samples (group A). The number of samples are indicated in the table in Figure 3. Dashed line: group A level.

Fig. 4.

Differential count of the major types of leukocytes according to neonatal status. The averages ± SD of % of neutrophils, lymphocytes, monocytes, eosinophils, and basophils according to different neonatal statuses (A–F) are shown. * Significant (p < 0.05) difference compared to the normal samples (group A). The number of samples are indicated in the table in Figure 3. Dashed line: group A level.

Close modal

CBC data of the samples were evaluated prior to the morphological analysis. As shown in Figure 1a, CBC-derived parameters pointed to significantly lower hemoglobin levels in the female CB samples (mean ± standard deviation 15.01 ± 1.46 g/dL) than the male CB samples (15.7 ± 1.66 g/dL). The lower hemoglobin levels in the female samples stemmed from lower red blood cell (RBC) numbers, rather than from differences in the mean hemoglobin concentrations (Fig. 1a). These differences are specific to the RBC lineage, and not to other blood components, such as white blood cells (WBCs) and platelets that were similar for the male and female samples (Fig. 1a). The manual differential count established the following values: 47.8 ± 10.7% neutrophils, 31.2 ± 9.8% lymphocytes, 10.0 ± 4.0% monocytes, and 3.0 ± 2.5% eosinophils, with no significant sex-related differences (Fig. 1b). As expected, low basophils levels were detected in the CB samples (0.5 ± 0.7%), with no sex-related differences for them either (data not shown). Analysis of left shift parameters (indicating an increase in the number of immature myeloid cells) revealed an average of 5.1 ± 4.1 bands, again with no sex-related difference (Fig. 1b). Only 7/100 samples had >10% bands, and one of them had 33% bands. Excluding the single exceptional sample, the mean band level was similar to the overall value (4.8 ± 3.0%). Other immature myeloid forms included the averages of 0.9 ± 0.9% metamyelocytes, 0.5 ± 0.7% myelocytes, and 0.6 ± 0.9% promyelocytes. Blasts were observed in 44/100 samples, with a mean of 0.5 ± 0.7% per sample. No morphological aberrations were observed in the myeloid cells. A detailed analysis of lymphocytes was carried out with the aim of evaluating the prevalence of informative forms, including normal lymphocytes, large granular lymphocytes (LGLs) (Fig. 2a), reactive lymphocytes (Fig. 2b), and aberrant lymphocytes (Fig. 2c). Some of the aberrant cells displayed immature nucleus, including blast-like nucleus, with nucleoli (Fig. 2c). The analysis revealed relatively high levels of reactive lymphocytes (8.3 ± 6.1% of the total lymphocytes), LGLs (19.1 ± 10.6% of the total lymphocytes), and aberrant lymphocytes (12.4 ± 5.4% of the total lymphocytes) (Fig. 2d). Aberrant lymphoid features that were observed included cells with cleft nuclei, nucleoli, split nuclei, reticulated nucleus, and irregular membranes (Fig. 2c).

Twelve of the 100 CB samples were from neonates born to mothers with hypothyroidism (n = 3), post term delivery (n = 3), cytomegalovirus infection during pregnancy (n = 1), selective serotonin reuptake inhibitors treatment by the mother (n = 1), antibiotic treatment during labor (n = 1) – all with small numbers (<5), and 3 that were not available for further analysis. Therefore, these 12 samples were excluded from further analysis. The remaining 88 samples included a group of 31 samples of neonates who were born to healthy mothers and were appropriate-for-GA, born at term, and had an APGAR score above 8 in 1 min (defined as normal). There were 14 samples of CB with a maternal diabetic background, 8 from small-for-gestational-age newborns, 20 from large-for-gestational-age newborns, 10 from preterm newborns, and 5 from newborns with low APGAR scores (Fig. 3). By definition, the cohort of preterm infants was defined by GA ≤37 (week 35 ± 3) and was also characterized by low weight, and small but significant lower APGAR 5 min scores (Fig. 3).

Analysis of CB samples according to neonatal status revealed no differences in hemoglobin and RBC levels (online suppl. Fig. 1). However, specific low WBC and platelets counts were observed in the preterm group, with some increase in the WBC counts in the low APGAR 5 min score group (online suppl. Fig. 1). While the differential counts were similar in most of the groups (with the exception of a relatively high neutrophil percentage in the maternal diabetic group), the preterm infants samples were noticeably different from the others (Fig. 4). Unlike the other samples which had relatively higher percentages of neutrophils and relatively lower percentages of lymphocytes, this ratio was reversed in the preterm group (Fig 4). These differences were not accompanied by changes in the left shift, and the proportions of immature neutrophils were similar for all clinical groups (data not shown). In addition, the eosinophil levels were higher in the preterm group (Fig. 4), but there was a single sample with 7.6% eosinophils which elevated the group mean that would otherwise be similar to that of the other groups (data not shown).

All samples contained low basophil counts, but it reached a level of significance only in the preterm group (Fig. 4), where 6/7 samples had no basophils whatsoever. Similar levels of reactive and aberrant lymphocytes were observed in all groups, with a small increase in the LGL neonates of the maternal diabetic group, the large-for-gestational-age group, and the low APGAR 5 min score group (Fig. 5).

Fig. 5.

Differential counts of lymphocytes subtypes according to neonatal status. The column patterns and samples numbers according to neonatal statuses are depicted in the table (right). The averages ± SD of % (of total lymphocytes) of normal lymphocytes, reactive lymphocytes LGL and aberrant lymphocytes, according to different neonatal statuses (A–F) are shown. *Significant (p < 0.05) difference compared to the normal samples (group A). GA, gestational age; LGL, large granular lymphocytes; SD, standard deviation.

Fig. 5.

Differential counts of lymphocytes subtypes according to neonatal status. The column patterns and samples numbers according to neonatal statuses are depicted in the table (right). The averages ± SD of % (of total lymphocytes) of normal lymphocytes, reactive lymphocytes LGL and aberrant lymphocytes, according to different neonatal statuses (A–F) are shown. *Significant (p < 0.05) difference compared to the normal samples (group A). GA, gestational age; LGL, large granular lymphocytes; SD, standard deviation.

Close modal

Nucleated red blood cells (NRBC) were detected in 92/100 samples. Most samples contained 5–10 NRBC/100 WBC, with a mean of 5.7 ± 6.2 NRBC/100 WBC (Fig. 6). 96/100 samples contained up to 20 NRBC/100 WBC. The samples with >15 NRBC/100 WBC included 2 among the samples of the normal group, 2 in the small-for-gestational-age group, 1 in the preterm group, and 1 in the maternal diabetic group. The morphological assessment of the RBCs pointed to large RBC as the main characteristic of all samples, compatible with high MCV values of these samples (average 109.4 ± 4.3, range 97.7–123.1 fL). Also, relatively high prevalence of small RBC and polychromasia were observed, and the prevalence of echinocytes to a lesser extent (Fig. 6).

Fig. 6.

RBCs morphological analysis of cord blood samples. The predominant RBC morphological features (out of 100 samples) are depicted in the table (right). Samples were scored positive only if at least 5–10% of the RBC in the sample had the designated morphology. Left: number of NRBC/100 WBC in cord blood samples. Samples were divided into groups according to their NRBC content. Arrow – the mean NRBC/100 WBC per cord blood sample (5.7 ± 6.2). RBCs, red blood cells; NRBC, nucleated red blood cells; WBCs, white blood cells.

Fig. 6.

RBCs morphological analysis of cord blood samples. The predominant RBC morphological features (out of 100 samples) are depicted in the table (right). Samples were scored positive only if at least 5–10% of the RBC in the sample had the designated morphology. Left: number of NRBC/100 WBC in cord blood samples. Samples were divided into groups according to their NRBC content. Arrow – the mean NRBC/100 WBC per cord blood sample (5.7 ± 6.2). RBCs, red blood cells; NRBC, nucleated red blood cells; WBCs, white blood cells.

Close modal

This study depicts the morphological abnormalities and the characteristics of normal CB in neonates. The current guidelines for the review of blood films do not include criteria for CB [14, 15], and while some reference ranges for CBC-derived parameters in neonatal CB samples have been documented in the past [10], no comparable determination exists for morphological parameters. Our data indicate that the CBC-derived parameters of our CB cohort reflect previously published data [10]. The most notable RBC morphological feature found in CB samples was the presence of large RBC, compatible with high MCV values of these samples. Large RBC are considered as normal for newborn RBC population [10, 14].

The morphological assessment of the leukocytes in our CB samples pointed to a limited left shift, with single blasts observed in about one-half of the samples. No morphological aberrations were observed in the myeloid cells. In contrast, transient abnormal myelopoiesis has a significantly higher prevalence of both blasts and immature granulocytes (sometimes with aberrant morphology) [16]. The differentials of preterm CB samples differed significantly from those of normal term samples, with lower neutrophils, high lymphocytes, and lower basophils percentages. In a previous study, CBC performed on preterm CB samples indicated low neutrophil counts in preterm compared to term CB samples, with no difference in lymphocyte counts between preterm and term CB samples [17].

A significant finding of the current study is the substantial presence of morphologically aberrant (or abnormal) lymphocytes in CB samples, which comprise an average of 12.4% and up to 25% of the lymphocytes population in CB samples. These cells were pre-classified by the CellaVision 1200 system as lymphocytes, but contained the following aberrations: increased cell size, immaturity of the nucleus, irregular nuclear outline or lobulation, cytoplasmic basophilia, and irregular cell outline. Hence, these cells were classified as aberrant lymphocytes according to previously published definition [14]. As we showed herein, such aberrations were abundant in the CB, and their presence was not associated with disease or specific neonatal conditions. In fact, morphologically aberrant lymphocytes were detected in all but one of the CB samples, and nearly 60% of the samples had >10% of morphologically aberrant lymphocytes in their lymphocyte populations.

Previous reports noted that incubation of PB samples in EDTA for prolonged periods (>30 min) may alter leukocytes morphology, and hence lymphocytes morphology may be affected as well [18, 19]. However, the average period in our institute from sample collection to CBC count and slide preparation is <30 min. Moreover, we did not detect any other morphological aberration in the other cell lineages in this study, and aberrant lymphocytes are not usually observed in normal PB samples processed in the laboratory in identical manner to the CB samples. This indicates that the high prevalence of aberrant lymphocytes do reflect the actual morphological appearance of lymphocytes in CB samples. In adults, aberrant (or abnormal) lymphocytes should be reported if they appear in significant numbers [14]. However, due to their high prevalence in CB normal samples, their presence in such samples may not be considered as abnormal.

Reactive lymphocytes typical for viral infections in adults were found in abundance in CB samples. We also observed an average of 19.1%, and up to 71.4% LGLs of the lymphocyte population in CB samples. Albeit LGL is not a definition of cell population characterized by flow cytometric analysis, the high prevalence of LGLs in CB observed by us may be similar to the previously reported high frequency of NK cells in CB [13]. The CB-derived NK cells may require further stimulation in order to achieve maturation and functionality of PB-derived NK cells [20].

Generally, the immune responses of neonates are considered to be less effective than those of mature immune systems [21]. In this context, it is interesting to note the low presence of basophils (an average of 0.75%) in the CB samples, and the near absence of these cells from preterm CB samples. Basophils participate in the regulation of type 2 immune responses by the production of cytokines, such as IL-4, IL-6, and TNFα [22, 23], and their low levels in the CB may be associated with the immature state of the immune system.

We conclude that the data presented herein point to a unique maturation status of immune cells in the CB, accompanied with exceptional morphological features, such as a high prevalence of LGLs and aberrant lymphocytes, which could be considered as abnormal in other age-groups. The differentials of preterm CB samples differ significantly from that of term CB samples, including the reverse of neutrophils/lymphocytes ratio, which may stem from different maturation status of the immune system, and alterations of hematopoiesis during gestation [17]. Morphological assessment of CB and newborn blood films is always a challenge, specifically for morphologists practicing adult blood film analysis. While aberrations in lymphoid cells morphology were not yet studied in CB samples, it was established that CB lymphocytes are significantly different compared to adult lymphocytes with respect to signaling, cytokines, and functional responses [20, 24, 25]. Hence, cells that appear abnormal in CB samples may, in fact, represent a normal, less mature stage of the immune system development, and not a source of concern.

We acknowledge Esther Eshkol, MA who provided assistance in preparing and editing the manuscript.

The research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki and by the local Institutional Review Board (IRB) at Tel Aviv Medical Center (Protocol No. 0501-20-TLV). Written informed consent was exempted by the IRB.

The authors have no conflicts of interest to declare.

There were no funding sources for this work.

B.K. designed and performed the study, and wrote the first draft. D.B., S.K., J.H., and C.R. made substantial contributions to the data analysis and interpretation of the work. R.M. made substantial contributions to the conception, design, and data interpretation, supervised the study, and revised the manuscript for important intellectual content. All authors revised the draft and had final approval of the version to be submitted. Lastly, all of the authors agreed to be accountable for all aspects of the work ensuring that questions related to the accuracy and integrity of any part of the work are appropriately investigated and resolved.

All raw data included in this manuscript are available from the corresponding author upon request.

1.
Diez
B
,
Genovese
P
,
Roman-Rodriguez
FJ
,
Alvarez
L
,
Schiroli
G
,
Ugalde
L
,
Therapeutic gene editing in CD34 hematopoietic progenitors from Fanconi anemia patients
.
EMBO Mol Med
.
2017
;
9
:
1574
88
.
2.
Singh
AK
,
McGuirk
JP
.
Allogeneic stem cell transplantation: a historical and scientific overview
.
Cancer Res
.
2016
;
76
:
6445
51
. .
3.
Medhekar
SK
,
Shende
VS
,
Chincholkar
AB
.
Recent stem cell advances: cord blood and induced pluripotent stem cell for cardiac regeneration: a review
.
Int J Stem Cells
.
2016
;
9
(
9
):
21
30
. .
4.
Peeters
B
,
Geerts
I
,
Van Mullem
M
,
Micalessi
I
,
Saegeman
V
,
Moerman
J
.
Post-test probability for neonatal hyperbilirubinemia based on umbilical cord blood bilirubin, direct antiglobulin test, and ABO compatibility results
.
Eur J Pediatr
.
2016
;
175
:
651
7
. .
5.
Cizmeci
MN
,
Kara
S
,
Kanburoglu
MK
,
Simavli
S
,
Duvan
CI
,
Tatli
MM
.
Detection of cord blood hepcidin levels as a biomarker for early-onset neonatal sepsis
.
Med Hypotheses
.
2014
;
82
:
310
2
. .
6.
Su
H
,
Chang
SS
,
Han
CM
,
Wu
KY
,
Li
MC
,
Huang
CY
,
Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-a systemic review and meta-analysis
.
J Perinatol
.
2014
;
34
:
268
74
.
7.
Prakash
N
,
Decristofaro
J
,
Maduekwe
ET
.
One less painful procedure: using umbilical cord blood as alternative source to admission complete blood count
.
Am J Perinatol
.
2017
;
34
:
1178
84
. .
8.
Greer
R
,
Safarulla
A
,
Koeppel
R
,
Aslam
M
,
Bany-Mohammed
FM
.
Can fetal umbilical venous blood be a reliable source for admission complete blood count and culture in NICU patients?
Neonatology
.
2019
;
115
:
49
58
. .
9.
Baer
VL
,
Lambert
DK
,
Carroll
PD
,
Gerday
E
,
Christensen
RD
.
Using umbilical cord blood for the initial blood tests of VLBW neonates results in higher hemoglobin and fewer RBC transfusions
.
J Perinatol
.
2013
;
33
:
363
5
. .
10.
Glasser
L
,
Sutton
N
,
Schmeling
M
,
Machan
JT
.
A comprehensive study of umbilical cord blood cell developmental changes and reference ranges by gestation, gender and mode of delivery
.
J Perinatol
.
2015
;
35
:
469
75
. .
11.
Gac
F
,
Thibert
JB
,
Le Berre
C
,
Le Priol
J
,
Semana
G
,
Fest
T
,
Evaluation of CytoDiff™ on cord blood WBC differential
.
Int J Lab Hematol
.
2013
;
35
:
46
54
.
12.
Roberts
I
,
OʼConnor
D
,
Roy
A
,
Cowan
G
,
Vyas
P
.
The impact of trisomy 21 on foetal haematopoiesis
.
Blood Cells Mol Dis
.
2013
;
51
:
277
81
. .
13.
Sarvaria
A
,
Jawdat
D
,
Madrigal
JA
,
Saudemont
A
.
Umbilical cord blood natural killer cells, their characteristics, and potential clinical applications
.
Front Immunol
.
2017
;
8
:
329
6
. .
14.
Palmer
L
,
Briggs
C
,
McFadden
S
,
Zini
G
,
Burthem
J
,
Rozenberg
G
,
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features
.
Int J Lab Hematol
.
2015
;
37
:
287
303
.
15.
Bain
BJ
.
Diagnosis from the blood Smear
.
N Engl J Med
.
2005
;
353
(
5
):
498
507
. .
16.
Roberts
I
,
Alford
K
,
Hall
G
,
Juban
G
,
Richmond
H
,
Norton
A
,
GATA1-mutant clones are frequent and often unsuspected in babies with down syndrome: identification of a population at risk of leukemia
.
Blood
.
2013
;
122
:
3908
17
.
17.
Rolim
ACB
,
Lambert
MA
,
Borges
JPG
,
Abbas
SA
,
Bordin
JO
,
Langhi Junior
DM
,
Blood cells profile in umbilical cord of late preterm and term newborns
.
Rev Paul Pediatr
.
2019
;
37
:
264
74
. .
18.
Narayanan
S
.
The preanalytic phase. An important component of laboratory medicine
.
Am J Clin Pathol
.
2000
;
113
:
429
52
. .
19.
Vives-Corrons
JL
,
Briggs
C
,
Simon-Lopez
R
,
Albarede
S
,
de la Salle
B
,
Flegar-Meatrii
Z
,
Effect of EDTA-anticoagulated whole blood storage on cell morphology examination. A need for standardization
.
Int J Lab Hematol
.
2014
;
36
:
222
6
.
20.
Shereck
E
,
Day
NS
,
Awasthi
A
,
Ayello
J
,
Chu
Y
,
McGuinn
C
,
Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56Dim NK cells
.
Innate Immun
.
2019
;
25
:
294
304
.
21.
Adkins
B
,
Leclerc
C
,
Marshall-Clarke
S
.
Neonatal adaptive immunity comes of age
.
Nat Rev Immunol
.
2004
;
4
:
553
64
. .
22.
Wynn
TA
.
Type 2 cytokines: mechanisms and therapeutic strategies
.
Nat Rev Immunol
.
2015
;
15
(
5
):
271
82
. .
23.
Yuk
CM
,
Park
HJ
,
Kwon
BI
,
Lah
SJ
,
Chang
J
,
Kim
JY
,
Basophil-derived IL-6 regulates T(H)17 cell differentiation and CD4 T cell immunity
.
Sci Rep
.
2017
;
7
:
417
44
.
24.
Nupponen
I
,
Kuuliala
A
,
Siitonen
S
,
Repo
H
,
Kuuliala
K
.
Cord blood monocytes, neutrophils and lymphocytes from preterm and full-term neonates show multiple aberrations in signalling profiles measured using phospho-specific whole-blood flow cytometry
.
Scand J Immunol
.
2013
;
78
:
426
38
. .
25.
Sato
K
,
Nagayama
H
,
Takahashi
TA
.
Aberrant CD3- and CD28-mediated signaling events in cord blood T cells are associated with dysfunctional regulation of Fas ligand-mediated cytotoxicity
.
J Immunol
.
1999
;
162
:
4464
71
.
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.